ArticleBioscience reports2024

Expression of Concern: HER2 decreases drug sensitivity of ovarian cancer cells via inducing stem cell-like property in a NFκB-dependent way.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.